Core Viewpoint - The Hong Kong IPO market is expected to maintain strong momentum in 2026, with a projected fundraising amount exceeding 300 billion HKD, driven by technology and A to H listings [12][18]. Group 1: IPO Market Overview - In 2025, Hong Kong's IPO market raised a total of 285.8 billion HKD, reclaiming the top position globally [12]. - As of the end of 2025, there were 316 companies waiting to go public, marking a peak in listing applications [14]. - The IPO market is characterized by a significant presence of leading companies across various sectors, including technology, biomedicine, and renewable energy [16]. Group 2: Key Drivers for 2026 - The IPO market in 2026 is expected to be supported by four main drivers: high-performing biotech companies, leading tech firms in AI and renewable energy, traditional industries undergoing transformation, and new consumer brands seeking international expansion [15][17]. - The influx of international long-term capital into the Hong Kong market is anticipated, favoring Chinese leading companies with strong growth and profitability [17]. Group 3: Predictions for 2026 - Multiple institutions predict that around 150 to 160 companies will successfully list in Hong Kong in 2026, with total fundraising estimates ranging from 320 billion to 350 billion HKD [18]. - The IPO landscape is expected to exhibit a "two ends large, middle differentiation" characteristic, where large projects and industry leaders attract stable long-term funding, while smaller projects may face greater valuation disparities [18]. Group 4: A to H Listings - A to H listings are expected to remain a significant component of the Hong Kong IPO market, providing more certainty for international investors due to their established business records and solid information disclosure [19]. - The demand for high-quality A to H assets reflects the market's interest in sectors such as technology, AI, biomedicine, and global consumer and manufacturing enterprises [19].

Group 1: IPO Market Overview - The Hong Kong IPO market experienced a strong recovery in the first half of 2025, with 42 companies raising a total of 1,067 million HKD, a 688% increase compared to the same period in 2024 [3][5] - The average fundraising amount per project was approximately 25.4 million HKD, surpassing the average levels from 2022 to 2024 [3] - The recovery was driven by large-cap stocks (A to H) which accounted for 72% of the total fundraising, while traditional sectors like industrials and finance faced challenges [3][5] Group 2: Key Players in the IPO Market - Seven A to H companies contributed 770 million HKD, with CATL leading at 410.1 million HKD, marking the largest IPO in nearly four years [5][6] - Other notable companies included 恒瑞医药 (113.7 million HKD), 海天味业 (101.3 million HKD), and 三花智控 (93.4 million HKD) [5][6] - The demand for these large-cap stocks was characterized by high subscription rates from both institutional and retail investors [5][6] Group 3: Sector Performance - The consumer discretionary and innovative pharmaceutical sectors saw significant interest, with retail investors driving high subscription rates [10][12] - The innovative pharmaceutical sector raised 40.6 million HKD with an average return of 78.4%, showcasing strong market interest despite a cautious institutional approach [12][13] - In contrast, traditional sectors like industrials and materials struggled, contributing only 130 million HKD to the total fundraising, reflecting a lack of investor confidence [15] Group 4: Subscription Trends - Subscription rates for A to H projects were notably high, with CATL seeing a retail subscription rate of 151.2 times, indicating strong demand for A-share assets [5][6] - The consumer sector, particularly companies like 蜜雪冰城, achieved record subscription rates, with 蜜雪冰城 raising 39.7 million HKD and achieving a subscription rate of 5,258.2 times [10][11] - The disparity in subscription rates highlights a trend where retail investors are more enthusiastic about new economy stocks compared to traditional sectors [10][15] Group 5: Future Outlook - The second half of 2025 is expected to see several A-share companies listing on the Hong Kong Stock Exchange, with fundraising levels anticipated to match those of the first half [7] - Focus is recommended on large-cap companies and industry leaders, particularly in sectors like pharmaceuticals and robotics, which are expected to attract investor interest [7]